Telatinib (Compound)

Compound:

telatinib (f66ba483-97f2-4ab8-b45a-fd204dc04351)

Synonyms:Telatinib, 332012-40-5, Bay 57-9352, Telatinib [INN], BAY-579352, telatinibum, BAY-57-9352, 4-[[4-(4-chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methylpyridine-2-carboxamide, UNII-18P7197Q7J, 18P7197Q7J

Pubchem:PUBCHEM:9808844

Id:3ad69e32-c40b-5975-8b48-7db614e1c220

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Telatinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Telatinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Telatinib.

Results found

Linked to

	Label	Description
	BRD-K84564571-001-02-4 Substance (Entity type)	A Substance
	Telatinib negatively regulates VAV3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Telatinib negatively regulates PLA2G2A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Telatinib positively regulates CEMIP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	telatinib (f66ba483-97f2-4ab8-b45a-fd204dc04351) Collection (Entity type)	Metadatata for telatinib
	Telatinib positively regulates GJA1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	4-(6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline in similarity relationship with Telatinib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Telatinib negatively regulates IL32 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Telatinib positively regulates GNAS Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Telatinib negatively regulates DPYSL2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K84564571-001-02-4

Substance (Entity type)

A Substance

Telatinib negatively regulates VAV3

Knowledge Graph Assertion (Entity type)